Table of Contents page: JHEP Reports

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Editorial Board

Published in issue: August 2020

100157

Quality and reproducibility during the COVID-19 pandemic

Thierry Gustot

Published online: July 02, 2020

100141

Research Articles

Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD

Ariane Barros Diniz,
Maísa Mota Antunes,
Viviane Aparecida de Souza Lacerda,
...
André Gustavo Oliveira,
Rafael Machado Rezende,
Gustavo Batista Menezes

Published online: April 20, 2020

100117

Should we use liver grafts repeatedly refused by other transplant teams?

Audrey Winter,
Paul Landais,
Daniel Azoulay,
...
Christian Jacquelinet,
Jean-Pierre Daurès,
Cyrille Féray

Published online: May 04, 2020

100118

Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C

Huiying Rao,
Huixin Liu,
Elizabeth Wu,
...
Robert J. Fontana,
Lai Wei,
Anna S. Lok

Published online: June 11, 2020

100136

Adding the oxygen carrier M101 to a cold-storage solution could be an alternative to HOPE for liver graft preservation

Pierre Alix,
David Val-Laillet,
Bruno Turlin,
...
Franck Zal,
Anne Corlu,
Karim Boudjema

Published online: May 07, 2020

100119

Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis

Maxime G. Zermatten,
Montserrat Fraga,
Debora Bertaggia Calderara,
Alessandro Aliotta,
Darius Moradpour,
Lorenzo Alberio

Published online: May 10, 2020

100120

IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer

Elsemieke de Vries,
Floor Tielbeke,
Lowiek Hubers,
...
Paul Fockens,
Niek de Vries,
Ulrich Beuers

Published online: April 14, 2020

100116

$Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis$

Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis

Pinelopi Arvaniti,
George Giannoulis,
Stella Gabeta,
Kalliopi Zachou,
George K. Koukoulis,
George N. Dalekos

Published online: May 27, 2020

100123

Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?

Carmen Espinós,
Peter Ferenci

Published online: April 18, 2020

100114

The liver matrisome – looking beyond collagens

Gavin E. Arteel,
Alexandra Naba

Published online: April 18, 2020

100115

New frontiers in liver resection for hepatocellular carcinoma

Manon Allaire,
Claire Goumard,
Chetana Lim,
Aline Le Cleach,
Mathilde Wagner,
Olivier Scatton

Published online: June 04, 2020

100134

Where does TIPS fit in the management of patients with cirrhosis?

Juan Carlos García-Pagán,
Saad Saffo,
Mattias Mandorfer,
Guadalupe Garcia-Tsao

Published online: May 23, 2020

100122

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease

Lucas A. Schulte,
Frank Arnold,
Florian Siegel,
...
Thomas Seufferlein,
Martin Müller,
Alexander Kleger

Published online: June 02, 2020

100135

Copyright and information